2001
DOI: 10.1126/science.1063525
|View full text |Cite
|
Sign up to set email alerts
|

Triallelic Inheritance in Bardet-Biedl Syndrome, a Mendelian Recessive Disorder

Abstract: Bardet-Biedl syndrome (BBS) is a genetically heterogeneous disorder characterized by multiple clinical features that include pigmentary retinal dystrophy, polydactyly, obesity, developmental delay, and renal defects. BBS is considered an autosomal recessive disorder, and recent positional cloning efforts have identified two BBS genes (BBS2 and BBS6). We screened our cohort of 163 BBS families for mutations in both BBS2 and BBS6 and report the presence of three mutant alleles in affected individuals in four ped… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

14
420
2
12

Year Published

2002
2002
2015
2015

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 581 publications
(448 citation statements)
references
References 27 publications
14
420
2
12
Order By: Relevance
“…Although we cannot exclude the possibility that a second pathogenic mutation resides within intronic or regulatory regions of the gene, it is also plausible that the identified change could act as a genetic modifier of the clinical phenotype in an oligogenic context, and that digenic mutations may reside in another gene. This intriguing mechanism has been already postulated for several ciliopathies including Bardet-Biedl syndrome, NPH and even JSRD, [22][23][24][25] and could also help explain the intra-familial variability observed in some INPP5E-mutated families. To this end, the systematic genetic screening of multiple ciliopathy genes based on innovative technologies such as next-generation-sequencing is expected to give a main contribution to clarify the molecular basis underlying the clinical complexity of JSRD and other ciliopathies.…”
Section: Discussionmentioning
confidence: 58%
“…Although we cannot exclude the possibility that a second pathogenic mutation resides within intronic or regulatory regions of the gene, it is also plausible that the identified change could act as a genetic modifier of the clinical phenotype in an oligogenic context, and that digenic mutations may reside in another gene. This intriguing mechanism has been already postulated for several ciliopathies including Bardet-Biedl syndrome, NPH and even JSRD, [22][23][24][25] and could also help explain the intra-familial variability observed in some INPP5E-mutated families. To this end, the systematic genetic screening of multiple ciliopathy genes based on innovative technologies such as next-generation-sequencing is expected to give a main contribution to clarify the molecular basis underlying the clinical complexity of JSRD and other ciliopathies.…”
Section: Discussionmentioning
confidence: 58%
“…Both mouse lines had skewed mendelian ratios, with 40-50% embryonic lethality evident by embryonic day 10.5 as partially reabsorbed embryos. Consistent with an oligogenic causality model 18,20 , Bbs1-null and Bbs4-null mice had considerable phenotypic Figure 3 Defects in olfactory protein localization in Bbs1 -/-and Bbs4 -/-mice. Sections of olfactory epithelium were immunostained with antibodies to olfactory cilia-enriched signal transduction components (AC III and G g13 ) and to the dendrite, dendritic knob and cilia protein SLP3.…”
mentioning
confidence: 72%
“…32 Although traditionally considered an autosomal recessive condition, there are several reported cases of a triallelic mode of inheritance where three mutations in BBS genes are required before the phenotype becomes apparent, or alternatively where a third disease locus acts as a disease modifier. 7,[33][34][35][36] As well as the phenotypic overlaps exhibited between ciliopathies, there is an emerging evidence suggesting that genes mutated in BBS and other ciliopathies exhibit some genetic overlap. 37 For example, mutations in BBS2, BBS4 and BBS6 have been identified in patients with Meckel syndrome.…”
Section: Genetic Basis Of the Diseasementioning
confidence: 99%
“…5,6 Inheritance is traditionally considered autosomal recessive, although notable exceptions exist, whereby BBS may be an oligogenic disorder. 7 The prevalence of BBS varies markedly between populations; from 1:160 000 in northern European populations 5 to 1:13 500 and 1:17 5000, respectively, in isolated communities in Kuwait and Newfoundland, where a higher level of consanguinity prevails. 8,9 Studies on the families in Newfoundland affected with BBS revealed a minimum of six BBS loci and eight different BBS mutations and therefore the high prevalence cannot be attributed to a single founder.…”
Section: Introductionmentioning
confidence: 99%